These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30802319)

  • 21. Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?
    Glutsch V; Kneitz H; Goebeler M; Gesierich A; Schilling B
    Ann Oncol; 2019 Oct; 30(10):1667-1668. PubMed ID: 31350554
    [No Abstract]   [Full Text] [Related]  

  • 22. Avelumab: A Novel Anti-PD-L1 Agent in the Treatment of Merkel Cell Carcinoma and Urothelial Cell Carcinoma.
    Teets A; Pham L; Tran EL; Hochmuth L; Deshmukh R
    Crit Rev Immunol; 2018; 38(3):159-206. PubMed ID: 30004857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report.
    Cardis MA; Jiang H; Strauss J; Gulley JL; Brownell I
    BMC Cancer; 2019 Jun; 19(1):539. PubMed ID: 31164102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Merkel cell carcinoma in chronic lymphocytic leukemia : Successful treatment with PD-L 1 inhibition, avelumab and chlorambucil].
    Dücker P; Hüning S; Rohde S; Lorenzen J; Nashan D
    Hautarzt; 2020 Jul; 71(7):553-556. PubMed ID: 32394077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.
    Grignani G; Chiarion Sileni V; Pinto C; Depenni R; Fazio N; Galli L; Giuffrida D; Carnaghi C; Ciliberto D; Corsi DC; Queirolo P; Benincasa E; Venturini F; Fazzi G; Costa N; Ascierto PA
    J Transl Med; 2021 Feb; 19(1):70. PubMed ID: 33588870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Avelumab in gastric cancer.
    Roviello G; D'Angelo A; Generali D; Pittacolo M; Ganzinelli M; Iezzi G; Manzini N; Sobhani N
    Immunotherapy; 2019 Jun; 11(9):759-768. PubMed ID: 31060469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merkel cell carcinoma presenting as right leg edema in a multiple myeloma patient.
    Noell CM; Rose E; Nesbitt LT
    J Am Acad Dermatol; 2014 Aug; 71(2):e50-2. PubMed ID: 25037813
    [No Abstract]   [Full Text] [Related]  

  • 28. Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab.
    Lanitis T; Proskorovsky I; Ambavane A; Hunger M; Zheng Y; Bharmal M; Phatak H
    Adv Ther; 2019 Sep; 36(9):2327-2341. PubMed ID: 31350728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Merkel cell carcinoma: case report and literature review.
    Sánchez-García S; Manzanares-Campillo C; Menéndez-Sánchez P; Muñoz-Atienza V; Martín-Fernández J
    Cir Cir; 2012; 80(1):63-6. PubMed ID: 22472155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avelumab and other recent advances in Merkel cell carcinoma.
    Bommareddy PK; Kaufman HL
    Future Oncol; 2017 Dec; 13(30):2771-2783. PubMed ID: 28976209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab.
    Thiem A; Kneitz H; Schummer P; Herz S; Schrama D; Houben R; Goebeler M; Schilling B; Gesierich A
    Acta Derm Venereol; 2017 Nov; 97(10):1252-1254. PubMed ID: 28761962
    [No Abstract]   [Full Text] [Related]  

  • 32. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
    Baker M; Cordes L; Brownell I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab.
    Eshghi N; Lundeen TF; MacKinnon L; Avery R; Kuo PH
    Clin Nucl Med; 2018 May; 43(5):e142-e144. PubMed ID: 29538029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma.
    Joseph J; Zobniw C; Davis J; Anderson J; Trinh VA
    Ann Pharmacother; 2018 Sep; 52(9):928-935. PubMed ID: 29616562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of Merkel cell carcinoma and recent advances in research.
    Smith K; Skelton H
    Int J Dermatol; 2003 Sep; 42(9):749-51. PubMed ID: 12956696
    [No Abstract]   [Full Text] [Related]  

  • 36. [Severe necrotizing myopathy subsequent to Merkel cell carcinoma].
    Hocar O; Poszepczynska-Guigné E; Faye O; Wechsler J; Bagot M; Buffard V
    Ann Dermatol Venereol; 2011 Feb; 138(2):130-4. PubMed ID: 21333825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
    Dasanu CA; Del Rosario M; Codreanu I; Hyams DM; Plaxe SC
    J Oncol Pharm Pract; 2019 Jan; 25(1):214-216. PubMed ID: 29933728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merkel cell carcinoma.
    Miller SJ; Alam M; Andersen J; Berg D; Bichakjian CK; Bowen G; Cheney RT; Glass F; Grekin RC; Grichnik JM; Johnson TM; Kessinger A; Lee NY; Lessin S; Lydiatt DD; Margolis LW; Nehal KS; Nghiem P; Oseroff AR; Rosenberg EW; Shaha AR; Siegle RJ;
    J Natl Compr Canc Netw; 2006 Aug; 4(7):704-12. PubMed ID: 16884672
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma.
    Sakaida E; Ebata T; Iwasawa S; Kurimoto R; Yonemori S; Ota S; Nakatani Y; Sekine I; Takiguchi Y
    Intern Med; 2017; 56(5):567-570. PubMed ID: 28250307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ipilimumab has efficacy in metastatic Merkel cell carcinoma: a case series of five patients.
    Winkler JK; Dimitrakopoulou-Strauss A; Sachpekidis C; Enk A; Hassel JC
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e389-e391. PubMed ID: 28256019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.